透過您的圖書館登入
IP:3.144.243.184
  • 期刊

Primary Tumor Volume and Treatment Outcome in T3-staged Nasopharyngeal Carcinoma

腫瘤分期T3鼻咽癌之原發腫瘤體積對治療結果之影響

摘要


背景及目的:在以放射線治療為主的癌症當中,原發腫瘤體積已被視為是重要的預後因素,尤其在腫瘤分期T3頭頸癌,腫瘤體積的變異性相當大。在鼻咽癌,這方面的研究卻付之闕如,因此,本研究的目的在探討腫瘤分期T3鼻咽癌的原發腫瘤體積對治療結果的影響。 方法:以高解析度電腦斷層使用區域合成法(summation of area technique)精算40位腫瘤分期T3鼻咽癌之原發腫瘤體積,並與治療之存活曲線做統計分析。 結果:原發腫瘤體積大於30毫升的預後明顯較差,且達統計顯著性(P=0.0001)。Cox迴歸分析顯示原發腫瘤體積是唯一的預後因子(P=0.011)。 結論:同樣腫瘤分期T3的鼻咽癌病人,原以腫瘤體積較大者預後較差,因此,應給予更積極的治療方法。

並列摘要


Background and purpose: Tumor volume is an important prognostic factor in patients with malignancy who are treated with primary radiotherapy. A substantial variability in the T3-staged head and neck cancers has been observed. We assessed the relationship between primary tumor volume and treatment outcome in T3-staged nasopharyngeal carcinoma. Methods: Forty newly diagnosed T3-staged patients who were treated with high dose radiation therapy participated in the study. Computed tomography-derived primary tumor volume was obtained from the summation of area technique. Results: The median primary tumor volume was 29.6mL (range, 8.0-131.8mL). After segregating the primary tumor volume into 2 subgroups (≤30mL, >30mL), large primary tumor volume was associated with a significantly poorer disease-specific survival (P=0.0001). The Cox proportional hazards regression model revealed that only primary tumor volume was statistically significant (P=0.011). Conclusion: In T3-staged nasopharyngeal carcinoma, a substantial variation of primary tumor volume was observed. Volumetric measurements of primary tumors in T3-staged nasopharyngeal carcinoma could better refine our treatment strategy.

延伸閱讀